Results 131 to 140 of about 92,839 (346)
Clinically Significant Neuroimaging Findings Among Pediatric Patients Presenting to the Emergency Department With Symptoms of Psychosis: A Multicenter Retrospective Study
Academic Emergency Medicine, EarlyView.ABSTRACT Background
The clinical utility of diagnostic neuroimaging for pediatric patients presenting to the emergency department (ED) for psychosis remains unclear. We sought to estimate the prevalence of and characteristics associated with clinically significant neuroimaging findings among pediatric patients presenting to the ED with symptoms of ...Jennifer A. Hoffmann, Tapan K. Parikh, Doug Lorenz, Michael P. Goldman, Emily M. Powers, Shilpa J. Patel, Ilana S. Lavina, Theodore W. Heyming, Jasmin T. England, Mohsen Saidinejad, Ilene Claudius, Pallavi Ghosh, Daniel J. Shapiro, Tricia B. Swan, Kamali L. Bouvay, Eileen Murtagh Kurowski, Nadine M. Smith, Justin R. Davis, Alexander B. Moxam, Eli J. Muhrer, Rohit P. Shenoi, Elyse N. Portillo, Ron L. Kaplan, Neil G. Uspal, Robert M. Lapus, Andrea T. Vo, Daniel B. Fenster, Danielle B. Barrocas, Deborah R. Liu, Pradip P. Chaudhari, Rachel Cafferty, Stephen B. Freedman, Jerri A. Rose, Megan F. Evers, Ashley M. Metcalf, Fareed Saleh, Jennifer Dunnick, Raymond D. Pitetti, Yashas R. Nathani, Muhammad Waseem, Todd A. Florin, on behalf of the Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) Psychosis Study Group +41 morewiley +1 more sourcePredicting Response to Pro‐Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction
Major depressive disorder (MDD) and bipolar disorder (BD) are often associated with persistent cognitive deficits that impair psychosocial functioning. While pro‐cognitive interventions show promise, trial findings are inconsistent, potentially due to baseline factors influencing treatment response.Dimosthenis Tsapekos, Michail Kalfas, Johanna M. Schandorff, Caterina del Mar Bonnin, Christopher R. Bowie, Vicent Balanzá‐Martínez, Katherine E. Burdick, Andre F. Carvalho, Annemieke Dols, Katie Douglas, Peter Gallagher, Gregor Hasler, Lars V. Kessing, Hanne L. Kjærstad, Beny Lafer, Kathryn E. Lewandowski, Carlos López‐Jaramillo, Anabel Martinez‐Aran, Roger S. McIntyre, Richard J. Porter, Scot E. Purdon, Ayal Schaffer, Paul R. A. Stokes, Tomiki Sumiyoshi, Ivan J. Torres, Tamsyn E. Van Rheenen, Lakshmi N. Yatham, Jeff Zarp, Allan H. Young, Eduard Vieta, Kamilla W. Miskowiak +30 morewiley +1 more sourceAssociation Between Metabolic Syndrome, Obesity, and Cognitive Performances in Individuals With Bipolar Disorders: Cross‐Sectional and Longitudinal Analyses in the FACE‐BD Cohort
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction
Metabolic syndrome (MetS) has been suggested to be associated with cognitive impairments in bipolar disorder (BD); however, studies are limited by small sample sizes or cross‐sectional design. Our objective is to evaluate the cross‐sectional and longitudinal associations between MetS and cognitive performances in a large cohort of I. Palimaru, B. Etain, M. Leboyer, Y. Dansou, P. Favre, S. Gard, V. Aubin, F. Bellivier, R. Belzeaux, P. Courtet, C. Dubertret, E. Haffen, A. Lefrere, P. M. Llorca, E. Olié, M. Polosan, L. Samalin, R. Schwan, the FondaMental Academic Centers of Expertise in Bipolar Disorders (FACE‐BD) Collaborators, B. Etain, E. Olié, M. Leboyer, E. Haffen, P. M. Llorca, V. Barteau, S. Bensalem, O. Godin, H. Laouamri, K. Souryis, S. Hotier, A. Pelletier, F. Hergeta, J. Petrucci, L. Willaume, F. Bellivier, B. Etain, V. Hennion, E. Marlinge, J. Meheust, A. Richard, M. Carminati, H. Francisque, S. Gard, K. M’Bailara, C. Elkael, F. Hoorelbeke, I. Minois, J. Sportich, N. Da Ros, C. Dubertret, N. Mazer, C. Portalier, C. Scognamiglio, A. Bing, P. Laurent, L. Boukhobza, P. Courtet, S. Denat, B. Deffinis, D. Ducasse, M. Gachet, A. Lengvenyté, F. Molière, L. Nass, E. Olié, G. Tarquini, A. Lefrere, E. Moreau, J. Pastol, F. Groppi, H. Polomeni, J. Bauberg, L. Lescalier, I. Muraccioli, A. Suray, R. Cohen, J. P. Kahn, M. Milazzo, O. Wajsbrot‐Elgrabli, T. Bougerol, A. Pouchon, A. Bertrand, B. Fredembach, A. Suisse, Q. Denoual, M. Polosan, A. M. Galliot, L. Brehon, G. Bonny, L. Durand, V. Feuga, N. Kayser, P. Roux, V. Aubin, I. Cussac, M. A. Dupont, J. Loftus, I. Medecin, C. Dubertret, N. Mazer, P. Laurent, L. Samalin, P. M. Llorca, M. Mennetrier, T. Bonnet, D. Lacelle, M. Vayssié, C. Beal, O. Blanc, P. Roux, O. Godin +110 morewiley +1 more sourceTrends in the multiple prescriptions of hypnotic drugs in a university outpatient in Japan
Neuropsychopharmacology ReportsAims In Japan, the daily dosage of hypnotic drugs for insomnia treatment is increasing year by year, and over‐dependence on treatment with hypnotic drugs is a major problem.Takao Kato, Nozomu Kotorii, Motohiro Ozone, Kenta Murotani, Hayato Ohshima, Hiroyuki Mori, Kenjirou Wasano, Hiroshi Hiejima, Mitsunari Habukawa, Naohisa Uchimura +9 moredoaj +1 more sourceNo Effect of Low‐Dose Aspirin Versus Placebo as Add‐On Treatment in Bipolar Disorder—Results From a Randomised Controlled Trial (the A‐Bipolar RCT)
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction
Robust evidence associates immunoinflammatory dysfunction and bipolar disorder (BD), with immune dysregulation present in patients newly diagnosed with BD. This suggests that anti‐inflammatory agents, like low‐dose aspirin (LDA), might be repurposed in the treatment of early‐stage BD.Caroline Fussing Bruun, Helle B. Krogh, Jeff Zarp, Julie Ravneberg Stokholm, Julie Lyng Forman, Kamilla Woznica Miskowiak, Annamaria Giraldi, Maj Vinberg, Maria Faurholt‐Jepsen, Lars Vedel Kessing +9 morewiley +1 more source